Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert R Henry

Showing results (51-60 of 155) with videos related to

Pageof 16
Sort By:
Adipocyte|April 28, 2022
Adipose tissue from subjects with type 2 diabetes exhibits impaired capillary formation in response to GROα: involvement of MMPs-2 and -9Yifat Amir Levy, Theodore P Ciaraldi, Sunder R Mudaliar, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 7, 2015
Excessive secretion of IL-8 by skeletal muscle in type 2 diabetes impairs tube growth: potential role of PI3K and the Tie2 receptorYifat Amir Levy, Theodore P Ciaraldi, Sunder R Mudaliar, et al.
Journal of Diabetes and Its Complications|January 4, 2006
Diabetes treatments have differential effects on nontraditional cardiovascular risk factorsVivian A Fonseca, Pierre Theuma, Sunder Mudaliar, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 31, 2008
Adiponectin secretion and response to pioglitazone is depot dependent in cultured human adipose tissueSusan A Phillips, Theodore P Ciaraldi, Deborah K Oh, et al.
Diabetes|June 28, 2002
Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscleSvetlana E Nikoulina, Theodore P Ciaraldi, Sunder Mudaliar, et al.
Diabetes Care|January 6, 2018
Clinical Impact of ITCA 650, a Novel Drug-Device GLP-1 Receptor Agonist, in Uncontrolled Type 2 Diabetes and Very High Baseline HbA<sub>1c</sub>: The FREEDOM-1 HBL (High Baseline) StudyRobert R Henry, Julio Rosenstock, Douglas S Denham, et al.
Soft Matter|September 16, 2020
Driven topological transitions in active nematic filmsDavid P Rivas, Tyler N Shendruk, Robert R Henry, et al.
American Journal of Physiology. Endocrinology and Metabolism|April 18, 2003
Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjectsHubertina M Wilmsen, Theodore P Ciaraldi, Leslie Carter, et al.
Journal of Diabetes and Its Complications|February 25, 2014
Reductions in systolic blood pressure with liraglutide in patients with type 2 diabetes: insights from a patient-level pooled analysis of six randomized clinical trialsVivian A Fonseca, J Hans Devries, Robert R Henry, et al.
Diabetes Care|May 7, 2013
Randomized trial of continuous subcutaneous delivery of exenatide by ITCA 650 versus twice-daily exenatide injections in metformin-treated type 2 diabetesRobert R Henry, Julio Rosenstock, Douglas K Logan, et al.
Pageof 16

Showing results (51-60 of 155) with videos related to

Sort By:
Pageof 16
Adipocyte|April 28, 2022
Adipose tissue from subjects with type 2 diabetes exhibits impaired capillary formation in response to GROα: involvement of MMPs-2 and -9Yifat Amir Levy, Theodore P Ciaraldi, Sunder R Mudaliar, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 7, 2015
Excessive secretion of IL-8 by skeletal muscle in type 2 diabetes impairs tube growth: potential role of PI3K and the Tie2 receptorYifat Amir Levy, Theodore P Ciaraldi, Sunder R Mudaliar, et al.
Journal of Diabetes and Its Complications|January 4, 2006
Diabetes treatments have differential effects on nontraditional cardiovascular risk factorsVivian A Fonseca, Pierre Theuma, Sunder Mudaliar, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 31, 2008
Adiponectin secretion and response to pioglitazone is depot dependent in cultured human adipose tissueSusan A Phillips, Theodore P Ciaraldi, Deborah K Oh, et al.
Diabetes|June 28, 2002
Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscleSvetlana E Nikoulina, Theodore P Ciaraldi, Sunder Mudaliar, et al.
Diabetes Care|January 6, 2018
Clinical Impact of ITCA 650, a Novel Drug-Device GLP-1 Receptor Agonist, in Uncontrolled Type 2 Diabetes and Very High Baseline HbA<sub>1c</sub>: The FREEDOM-1 HBL (High Baseline) StudyRobert R Henry, Julio Rosenstock, Douglas S Denham, et al.
Soft Matter|September 16, 2020
Driven topological transitions in active nematic filmsDavid P Rivas, Tyler N Shendruk, Robert R Henry, et al.
American Journal of Physiology. Endocrinology and Metabolism|April 18, 2003
Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjectsHubertina M Wilmsen, Theodore P Ciaraldi, Leslie Carter, et al.
Journal of Diabetes and Its Complications|February 25, 2014
Reductions in systolic blood pressure with liraglutide in patients with type 2 diabetes: insights from a patient-level pooled analysis of six randomized clinical trialsVivian A Fonseca, J Hans Devries, Robert R Henry, et al.
Diabetes Care|May 7, 2013
Randomized trial of continuous subcutaneous delivery of exenatide by ITCA 650 versus twice-daily exenatide injections in metformin-treated type 2 diabetesRobert R Henry, Julio Rosenstock, Douglas K Logan, et al.
Pageof 16